Sunday, July 6, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Exports

HitGen and SPARC Enter DNA-Encoded Library Based Research

Fiinews by Fiinews
March 13, 2019
in Exports, Health, Manufacturing
Reading Time: 2 mins read
A A
0
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Chengdu-Mumbai Drug Research Collaboration

 

HitGen.

HitGen Ltd and Sun Pharma Advanced Research Company Ltd have announced a research collaboration to identify novel small molecule leads for targets of interest.

Under this collaboration, announced 12 Mar 2019, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for SPARC. Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

“We are delighted to enter into collaboration with SPARC, a global pharmaceutical company headquartered in Mumbai. This collaboration further emphasizes the role of HitGen in the rapidly developing field of DNA-encoded chemistry,” said Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen.

“We will work closely with SPARC scientists to generate novel leads for their innovative research programs to address unmet medical needs,” Said Dr Li.

“We believe HitGen’s unique DNA-encoded library-based screening platform combined with SPARC’s in-house research expertise, shall accelerate our drug discovery efforts. We look forward to collaborating with HitGen to bring innovative medicines for patients with serious medical conditions.” said Anil Raghavan, CEO of SPARC.

HitGen is a rapidly growing biotech company with headquarters and main research facilities based in Chengdu, China and with a subsidiary in the USA.

HitGen has established a platform for small molecule drug discovery centred on the design, assembly and interrogation of DNA encoded chemical libraries (DELs).

HitGen’s DELs contain nearly 400 billion novel, diverse, drug-like small molecule and macrocyclic compounds. These compounds are members of DELs synthesised from many hundreds of distinct chemical scaffolds, designed with tractable chemistry, and yielding proven results for the discovery of small molecule leads against precedented and unprecedented classes of biological targets.

HitGen is collaborating with pharmaceutical, biotech, and chemical companies, foundations and research institutes in North America, Europe, Asia and Africa to discover and develop approaches for novel medicines and agrochemical solutions.

Sun Pharma Advanced Research Company Ltd is a global pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery.

SPARC aims to consistently lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. fiinews.com

Tags: Sun Pharma Advanced Research Company Ltd
ShareTweetShare

Related Posts

SOPA
Exports

Export: India to ship non-GMO soybean to EU

by Fiinews
July 6, 2025
0
16

Global demand for deforestation-free non-GMO soy rises Indian non-GMO soy is a natural fit for EU buyers seeking sustainable and...

FICCI
Manufacturing

Manufacturing: Framework on Drones by Sep-Oct

by Fiinews
July 6, 2025
0
15

Lt Gen Singh urged industry to invest more on component level R&D Lt Gen Rahul R Singh, Deputy Chief of...

Toy Biz International2

Export: India supplies toys to 153 countries

July 6, 2025
19
Air Liquide

Manufacturing: Air Liquide builds ASU-CFS

July 5, 2025
13
NITI Aayog

Manufacturing: India’s chemical sector faces challenges

July 5, 2025
21
Ministry of Textile

Export: Govt to facilitate easy trade environment

July 2, 2025
15
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Export: India to ship non-GMO soybean to EU
  • Tender: Take care of new urban development
  • Manufacturing: Framework on Drones by Sep-Oct
  • Project: Joint maritime professionals launched
  • Market: Daimler bullish on construction sector

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.